As another member of the JADE family JADE1 has been linked to renal cancer pathogenesis through a VHL-mutation-dependent mechanism [62], we next sought to determine if JADE2 mRNA was also associated with mutation of key oncogenic driver mutations in NSCLC such as KRAS or ALK [4]. The gene discussed is JADE2; the disease is renal carcinoma.